MH

Michael Heffernan

Director Of Research & Technology at Fannin

Michael Heffernan is an experienced professional in biomedical engineering and product development, currently serving as the Vice President of Operations at Radiomer Therapeutics, focusing on novel radiopharmaceuticals. With a substantial tenure as the Director of Research & Technology at Fannin Innovation Studio, Michael has spearheaded early-stage biomedical technologies and product development for multiple medical device companies. Previously, Michael held key roles including Chief Operating Officer at Raptamer Discovery Group, LLC, and Assistant Professor at Baylor College of Medicine, where Michael concentrated on drug delivery systems and cancer therapies. Michael's educational background includes a Ph.D. in Biomedical Engineering from the Georgia Institute of Technology, an M.S. in Mechanical Engineering from Virginia Tech, and a B.S. in Mechanical Engineering and Materials Science from Duke University.

Location

Houston, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


Fannin

Fannin is an early-stage life sciences development group focused on commercializing innovation developed in the Texas Medical Center institutions. Led by an experienced team of managers with diverse business backgrounds, commercialization experience, and strong entrepreneurial knowhow, Fannin partners with promising life science innovators to co-found and actively manage startup companies. Fannin provides its startups with central office space, seed capital and a vast network of resources. To address the root cause of Houston’s commercialization gap, Fannin works directly with the city’s top-tier, higher education institutions to recruit aspiring entrepreneurs to join its apprenticeship program which provides on-the-job training to collaboratively lead its portfolio companies from innovation to commercialization. Future Outlook: Fannin has successfully validated this business model over the last seven years and is now in the process of scaling it up. Another 15-20 portfolio companies are expected to be developed in the next 3 - 5 years. For more information, email innovate@fannininnovation.com.


Employees

11-50

Links